Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04145843 · ClinicalTrials.gov registry record

Treatment Outcomes in Bile Duct Stones

A clinical trial, sponsored by AdventHealth.

Completed
Registry status
42
Enrollment target

NCT04145843 is a clinical trial that has completed, run by AdventHealth. The registered enrollment target is 42 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04145843 has completed, sponsored by AdventHealth.

COMPLETED
Registry status
42 participants
Enrollment target

Study Summary

This registry is to evaluate the procedural and clinical outcomes in patients undergoing endoscopic treatment of bile duct stones when utilizing an algorithmic management approach.

Interventions

  • PROCEDURE endoscopic retrograde cholangiopancreatography

Trial Details

FieldValue
Enrollment Target 42 participants
Start Date 2019-11-06
Est. Completion 2022-04-05

Sponsor

AdventHealth

95 total trials

What the Registry Record Tells You About NCT04145843

The ClinicalTrials.gov registry entry for NCT04145843 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AdventHealth, which has 95 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which endoscopic retrograde cholangiopancreatography is the first listed.

NCT04145843 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04145843 about?

NCT04145843 is a clinical study titled "Treatment Outcomes in Bile Duct Stones". This registry is to evaluate the procedural and clinical outcomes in patients undergoing endoscopic treatment of bile duct stones when utilizing an algorithmic management approach.

What is the current status of trial NCT04145843?

This trial is currently completed. The enrollment target is 42 participants. The study started on 2019-11-06. Estimated completion is 2022-04-05.

What interventions are being tested in trial NCT04145843?

The interventions under investigation include: endoscopic retrograde cholangiopancreatography (PROCEDURE).

Who is sponsoring clinical trial NCT04145843?

This trial is sponsored by AdventHealth, which has 95 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.